期刊文献+

心房颤动患者脑微出血的分布和相关危险因素分析

Distribution of cerebral microbleeds in patients with atrial fibrillation and related risk factors
下载PDF
导出
摘要 目的了解心房颤动患者脑微出血(CMBs)的比例和分布,分析房颤脑微出血患者的相关危险因素。方法选取2015年1月~2017年6月在我院住院且行头颅磁敏感加权成像检查的132例房颤患者。对所有患者采集一般临床资料,并对CMBs的数量和分布进行分析;采用Logistic回归分析房颤患者的相关危险因素。结果本研究中38例房颤患者(28.9%)合并有CMBs,其中9例患者(23.7%)CMBs病灶数为1个,17例患者(44.7%)病灶数为2~4个,12例患者(31.6%)病灶数≥5个。房颤CMBs患者总病灶数为183个,其中102个病灶(55.7%)位于脑叶,57个病灶(31.2%)位于深部,24个病灶(13.1%)位于幕下。回归分析提示年龄(OR=1.102,P=0.001,95%CI1.044~1.163)和抗凝治疗(OR=3.006,P=0.033,95%CI 1.091~8.281)是房颤患者CMBs的独立危险因素。结论房颤患者脑微出血病灶主要位于脑叶,对于年龄大且需要抗凝的房颤患者,建议行头颅磁敏感加权成像监测脑微出血。 Objective To understand the proportion and distribution of brain microbleeds(CMBs) in patients with atrial fibrillation, and to analyze the related risk factors of patients with atrial fibrillation. Methods A total of 132 patients with atrial fibrillation who were hospitalized in our hospital and underwent head-to-head magnetic sensitive weighted imaging examination from January 2015 to June 2017 were enrolled. General clinical data were collected from all patients, and the number and distribution of CMBs were analyzed. Logistic regression was used to analyze the risk factors associated with AF patients. Results In this study, 38 patients with atrial fibrillation(28.9%) had CMBs, 9 cases of whom(23.7%) had 1 CMBs, and 17 cases(44.7%) had 2-4 lesions, 12 patients(31.6%) had ≥5 lesions. The total number of lesions in patients with atrial fibrillation and CMBs was 183, of which 102 lesions(55.7%) were located in the brain lobe, 57 lesions(31.2%) were located deep, and 24 lesions(13.1%) were located under the curtain. Regression analysis suggested that age(OR=1.102, P=0.001, 95% CI 1.044-1.163)and anticoagulant therapy (OR=3.006, P=0.033, 95%CI 1.091-8.281) were independent risk factors for CMBs in patients with atrial fibrillation. Conclusion The brain microbleeds in patients with atrial fibrillation are mainly located in the cerebral lobe. For patients with atrial fibrillation who need anticoagulation, it is recommended to monitor brain mcrobleeds by magnetic sensitive imaging.
作者 王俊俊 刘小利 胡晓锋 WANG Junjun;LIU Xiaoli;HU Xiaofeng(Department of Neurology,Zhejiang Hospital,Hangzhou 310013,China;Department of Cardiology,Zhejiang Hospital,Hangzhou 310013, China)
出处 《中国现代医生》 2019年第8期84-87,共4页 China Modern Doctor
基金 浙江省卫生厅立项课题(2017KY002)
关键词 心房颤动 脑微出血 危险因素 抗凝治疗 Atrial fibrillation Cerebral microbleeds Risk factors Anticoagulant therapy
  • 相关文献

参考文献3

二级参考文献26

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1402
  • 2胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:162
  • 3Lonn E,Yusuf S,Arnold MJ,菅鑫妍.血管疾病中叶酸和B族维生素的使用不能降低高半胱氨酸浓度[J].中国处方药,2006,5(6):23-24. 被引量:136
  • 4中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 5Pstay BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation, 1997,96:2455-2461.
  • 6Kannel WB, Wolf PA Benjamin EJ, et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol ,1998,82:2N-9N.
  • 7Jouven X, Desnos M, Guerot C, et al. Idiopathic atrial fibrillation as a risk factor for mortality. The Paris Prospective Study Ⅰ. Eur Heart J, 1999,20:896-899.
  • 8Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med, 2002,347:1825-1833.
  • 9Hagens VE, Ranchor AV, Van Sonderen E,et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol,2004,43:241-247.
  • 10Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. Circulation,2001,104:2118-2150.

共引文献1041

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部